Abstract

p53 is a potent endogenous tumour suppressor agent which guards against DNA damage and prevents transformation of normal cells into malignant cells. In most forms of cancers except malignant melanoma, mutation occurs in p53 gene rendering it dysfunctional or suppressed. This research attempts to design novel putative bioactive oligopeptides from tumour suppressor p53 gene sequences using its promoter sequence and deriving several primer-based oligomers from the exons of p53 gene. p53 induces cells to undergo repair or apoptosis in response to DNA-damage induced stress and thus acts as the Warden of the Cell. We devise some novel methods to derive our de novo sequences from the exons of this gene and report discovery of two new oligopep-tides such as HRGRES and PAAPA (P 7 TA 7) peptide being two putative oligopeptides.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.